Triple-negative breast cancer (TNBC) is an aggressive breast cancer. It spreads quickly and has few treatment options. It is also serious because of its rate of recurrence.
People waiting more than 18 weeks for NHS treatments used more healthcare resources than others, research found.
Leukemia/cell therapy doc; Adolescent/Young Adult and ALL Leukemia Program Leader at Memorial Sloan Kettering Cancer Center. Indie rock and Boston sports fan. Opinions=my own. 💖💜💙…
A free, six module, self-directed program designed especially for healthcare providers to help you understand the core of patient safety.
Introduction Deprescribing ( medication dose reduction or cessation ) is an integral component of appropriate prescribing. The extent to which deprescribing recommendations are included in…
Identifying high and poorly performing organisations is common practice in healthcare. Often this is done within a frequentist inferential framework where statistical techniques are used…
Professional development is the strongest lever school leaders hold for increasing long-term student outcomes.
After two recent deaths in gene therapy clinical trials, the industry needs to be more open to sharing information to protect participants.
It’s time to end the “skin in the game” experiment in health insurance and reform the broken system.
Action The U.S. Food and Drug Administration has approved Alhemo (concizumab-mtci) for routine prophylaxis to prevent or reduce the frequency of bleeding
